Having trouble viewing this email? Click here .

May 2023    


New Report: Transformational Impact: Scaling and Sustaining High Impact Maternal Health Solutions


A new report from Merck highlights six social investments, funded through Merck for Mothers, and their paths toward impact, scale and sustainability to help reduce maternal mortality. The report highlights solutions that have demonstrated transformational impact on maternal health in vastly different contexts – from small private clinics in Maharashtra, India to a major hospital system in Bahia, Brazil.

Now Accepting Nominations for the 2023 Kenneth C. Frazier Award for Maternal Health Equity


We are now accepting nominations for the third annual Kenneth C. Frazier Award for Maternal Health Equity. The award is in recognition of the legacy and commitment to maternal health by Kenneth C. Frazier, our company's retired chairman and CEO. Merck for Mothers will bestow a new organization with this grant in recognition of their commitment to, and progress toward, more equitable, high-quality maternal health care.

New Grant Mechanism Seeks Applications for Scaling Postpartum Hemorrhage Medicines


Despite advances in evidence-based interventions and updated recommendations to improve clinical practice, progress to meet the Sustainable Development Goal 3.1 target to reduce the maternal mortality ratio has stagnated in the past decade. Severe bleeding after childbirth, or postpartum hemorrhage (PPH), has been and remains the leading cause of maternal mortality worldwide. To help address this issue, the Reproductive Health Supplies Coalition Maternal Health Caucus has announced a new small grants mechanism, co-funded through Merck for Mothers and the Foreign, Commonwealth & Development Office (FCDO), to increase access to new and lesser-used medications capable of preventing and treating PPH. The goal is to provide funding for government-endorsed, catalytic activities to introduce and scale these new PPH medicines in low- and lower-middle income countries.

Global Maternal Health Community Will #AlignTogether at the International Maternal and Newborn Health Conference 2023


Merck for Mothers is a proud sponsor of this year's International Maternal and Newborn Health Conference (IMNHC). For the first time in more than eight years, thousands of colleagues from around the world are coming together to accelerate solutions to improve maternal and newborn survival. This conference, coordinated by AlignMNH, will take place in Cape Town, South Africa from May 8-11.

If you no longer wish to receive updates from Merck for Mothers please click here to opt out.

At Merck, our global privacy program is based on building and preserving the trust of our stakeholders in how we protect personal information about them. Please read more about our privacy commitment . For more information, please read our Global Data Practices Notice for Healthcare Professionals .

If you have questions relating to Merck prescription products, your medical condition or personal health matters, please contact your physician or healthcare provider since he or she is most familiar with your medical condition. Merck cannot respond to questions about general medical information or information regarding your specific condition. To report an adverse experience with a specific Merck product, please call the Merck National Service Center at 800-444-2080 .

To ensure delivery of this e-newsletter, add newsletter@merckformothers.com to your address book.

This email was sent by: Merck for Mothers, Merck & Co., Inc., Rahway, NJ, USA